Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Mar;84(3):412-7.
doi: 10.1016/j.ajhg.2009.02.006. Epub 2009 Mar 5.

Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene

Eyal Shteyer  1 , Ann Saada, Avraham Shaag, Fida' Aziz Al-Hijawi, Rojette Kidess, Shoshanah Revel-Vilk, Orly Elpeleg
Affiliations

Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene

Eyal Shteyer et al. Am J Hum Genet. 2009 Mar.

Abstract

Steatorrhea and malabsorption of lipid-soluble vitamins due to exocrine pancreatic insufficiency are common in patients with cystic fibrosis and are predominant in Shwachman-Bodian-Diamond, Pearson, and Johanson-Blizzard syndromes. In four patients who suffered from congenital exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis, we excluded these disorders and identified, by using homozygosity mapping, a mutation in the COX4I2 gene. The COX4 protein is an essential structural subunit of cytochrome c oxidase complex and has two isoforms, encoded by two different genes. We show that the ratio of COX4I2 to COX4I1 mRNA is relatively high in human acinar cells. The mutation is associated with marked reduction of COX4I2 expression and with striking attenuation of the physiologic COX4I2 response to hypoxia. Mutation analysis of COX4I2 is warranted in patients with malabsorption due to exocrine pancreatic insufficiency and in patients with dyserythropoeitic anemia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pedigrees of Families A and B and the Haplotypes along the Critical Region on Chromosome 20 Patients' symbols are filled. Numbered symbols represent individuals whose DNA samples were available for analysis. The polymorphic microsatellite markers and their chromosomal locations (in Mb) are given in the upper left panel. C20-22.65M_TAT stands for hg18_chr20:22654664-22655109. C20-29.67M_CA stands for hg18_ chr20:29675861-29676305.
Figure 2
Figure 2
Skull and Abdominal Radiological Findings (A and B) Patient 1989's thickened calvarium: (A) Brain CT scan, axial view; (B) skull x-ray. (C and D) Abdominal CT scan of patients 1989 (C) and 3041 (D) disclosing pancreatic atrophy with massive fatty infiltration (arrows) and increased hepatic density (asterisk).
Figure 3
Figure 3
Bone marrow biopsy of patient 1989. Note multi-nucleated red cell precursors (solid arrows) and megaloblastic changes (dashed arrow)
Figure 4
Figure 4
The COX4I2 Mutation (A and B) Genomic fragment of the COX4I2 gene disclosing the c.412 G > A mutation (arrow) in a patient (A) and an obligate heterozygote (B). (C) normal control. (D) Conservation throughout evolution of the glutamic acid at codon 138 (bolded). D. Melano. stands for Drosophila melanogaster.
See this image and copyright information in PMC

References

    1. Rowntree R.K., Harris A. The phenotypic consequences of CFTR mutations. Ann. Hum. Genet. 2003;67:471–485. - PubMed
    1. Mack D.R., Forstner G.G., Wilschanski M., Freedman M.H., Durie P.R. Shwachman syndrome: Exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology. 1996;111:1593–1602. - PubMed
    1. Pearson H.A., Lobel J.S., Kocoshis S.A., Naiman J.L., Windmiller J., Lammi A.T., Hoffman R., Marsh J.C. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J. Pediatr. 1979;95:976–984. - PubMed
    1. Rotig A., Colonna M., Bonnefont J.P., Blanche S., Fischer A., Saudubray J.M., Munnich A. Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome. Lancet. 1989;1:902–903. - PubMed
    1. Larsson N.G., Holme E., Kristiansson B., Oldfors A., Tulinius M. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr. Res. 1990;28:131–136. - PubMed